Facts and Investment Opportunities in UK NHSChen Cao
This deck of presentation contains facts and investment opportunities in UK NHS after its newly restructuring, targeting on investors as primary audience base.
The Ministry of Health and Family Welfare developed the National Health Accounts (NHA) in 2001–02 to support the governance of health systems and enable the design of more effective health policies. This report provides an estimate of the total health expenditure for 2004-05 (taking into consideration the launch of the National Rural Health Mission in 2005), and gives provisional estimates of the health expenditure from 2005-06 to 2008-09.
In the computation of NHA, the World Health Organisation’s (WHO) definition of health expenditure was adopted. NHA includes expenditure on inpatient and outpatient care, hospitals, specialty hospitals, health promotion centres, rehabilitative care centres, capital expenditure on health, medical education, and research and training. It excludes expenses on water supply, sanitation, environmental health and the mid-day meal programme.
NHS finances: the challenge all policital parties need to face - charts and t...The Health Foundation
The NHS is one of the key issues of public concern in the run up to the 2015 general election and levels of concern have increased.
We have analysed the funding issues facing the NHS. This slidepack includes all the charts and tables from our research.
Find out more at wwww.health.org.uk/fundingbriefing
This case study looks at the key challenges facing the process of modernising the Serbian health system, including decentralisation, fragmentation, corruption and the lack of a transparent and comprehensive system for health technology assessment.
we explore the key challenges facing the process of modernising the Serbian health system, including decentralisation, fragmentation, corruption and the lack of a transparent and comprehensive system for health technology assessment.
Facts and Investment Opportunities in UK NHSChen Cao
This deck of presentation contains facts and investment opportunities in UK NHS after its newly restructuring, targeting on investors as primary audience base.
The Ministry of Health and Family Welfare developed the National Health Accounts (NHA) in 2001–02 to support the governance of health systems and enable the design of more effective health policies. This report provides an estimate of the total health expenditure for 2004-05 (taking into consideration the launch of the National Rural Health Mission in 2005), and gives provisional estimates of the health expenditure from 2005-06 to 2008-09.
In the computation of NHA, the World Health Organisation’s (WHO) definition of health expenditure was adopted. NHA includes expenditure on inpatient and outpatient care, hospitals, specialty hospitals, health promotion centres, rehabilitative care centres, capital expenditure on health, medical education, and research and training. It excludes expenses on water supply, sanitation, environmental health and the mid-day meal programme.
NHS finances: the challenge all policital parties need to face - charts and t...The Health Foundation
The NHS is one of the key issues of public concern in the run up to the 2015 general election and levels of concern have increased.
We have analysed the funding issues facing the NHS. This slidepack includes all the charts and tables from our research.
Find out more at wwww.health.org.uk/fundingbriefing
This case study looks at the key challenges facing the process of modernising the Serbian health system, including decentralisation, fragmentation, corruption and the lack of a transparent and comprehensive system for health technology assessment.
we explore the key challenges facing the process of modernising the Serbian health system, including decentralisation, fragmentation, corruption and the lack of a transparent and comprehensive system for health technology assessment.
Spending reviews - Stefan Kiss, Slovak RepublicOECD Governance
This presentation was made by Stefan Kiss, Slovak Republic, at the 3rd Health Systems Joint Network meeting for Central, Eastern and South-eastern European Countries held in Vilnius, Lithuania, on 25-26 April 2019
The ten Balkan countries examined in this report—Albania, Bosnia and Hercegovina, Bulgaria, Croatia, Kosovo, Macedonia, Montenegro, Romania, Serbia and Slovenia—continue to make slow progress in modernising their health systems.
With the NHS as the main area of public interest in the run-up to the 2015 general election, the Health Foundation and Ipsos MORI have conducted just under 1,800 interviews with adults across Great Britain to understand what the public thinks about the issues that are shaping debate on the NHS.
This presentation by David MOLONEY was made at the 3rd Joint DELSA/GOV Health Meeting, Paris 24-25 April 2014. Find out more at www.oecd.org/gov/budgeting/3rdmeetingdelsagovnetworkfiscalsustainabilityofhealthsystems2014.htm
This presentation was made by Kristina Garuoliene, Lithuania, at the 3rd Health Systems Joint Network meeting for Central, Eastern and South-eastern European Countries held in Vilnius, Lithuania, on 25-26 April 2019
Uzbekistan Pharmaceutical Country Report 9M 2019Eirhub
The Report uncovers 9M 2019 business trends of the pharmaceutical market in Uzbekistan, reviews its healthcare system, portrays its epidemiology and demographics. It also depicts pharma regulation features in Uzbekistan including a step-by-step process of the marketing authorization procedure for pharma products. It offers insight into the country’s sociopolitical development since independence, describes recent economic trends, and provides the local pharmaceutical sales forecast for the next three years (2019-2021).
2011 presentation to House Public Safety Appropriations Subcommitteeocpslides
Earlier this week, Director Jones presented this powerpoint presentation to the House Public Safety Appropriations Subcommittee. The Director thoroughly conveyed what an efficiently run agency the DOC is, as well as the desperate need for a supplemental, due in large part to unfunded offender population growth. The committee members had many questions, but didn't give an indication of whether or not a supplemental could be expected.
Assessing the European Commission's Proposal to Revise the Clinical Trial Dir...Cognizant
With a revision of the clinical trials directive impending, we offer a six-stage process for life sciences organizations to best prepare to capitalize on the changes in the CTD.
Budgeting for healthcare - Camila Vammalle, OECDOECD Governance
This presentation was made by Camila Vammalle, OECD, at the 11th Annual Meeting of Central, Eastern and South-Eastern Senior Budget Officials (CESEE SBO) held in Warsaw, Poland, on 21-22 May 2015.
mHealth israel_EU Go-To-Market for Digital Health, Julien Venne, European Con...Levi Shapiro
Presentation for mHealth Israel about "EU Go-To-Market for Digital Health", by Julien Venne, Strategic Advisory, European Connected Healthcare Alliance, Oct, 2016
Structure and governance of financing - Tamas Evetovits, WHOOECD Governance
This presentation was made by Tamas Evetovits, WHO, at the 2nd Health Systems joint Network Meeting for Central, Eastern and Southeastern European Countries held in Tallinn, Estonia, on 1-2 December 2016
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizens’ Health", on 5 March 2014, Athens, Greece.
Spending reviews - Stefan Kiss, Slovak RepublicOECD Governance
This presentation was made by Stefan Kiss, Slovak Republic, at the 3rd Health Systems Joint Network meeting for Central, Eastern and South-eastern European Countries held in Vilnius, Lithuania, on 25-26 April 2019
The ten Balkan countries examined in this report—Albania, Bosnia and Hercegovina, Bulgaria, Croatia, Kosovo, Macedonia, Montenegro, Romania, Serbia and Slovenia—continue to make slow progress in modernising their health systems.
With the NHS as the main area of public interest in the run-up to the 2015 general election, the Health Foundation and Ipsos MORI have conducted just under 1,800 interviews with adults across Great Britain to understand what the public thinks about the issues that are shaping debate on the NHS.
This presentation by David MOLONEY was made at the 3rd Joint DELSA/GOV Health Meeting, Paris 24-25 April 2014. Find out more at www.oecd.org/gov/budgeting/3rdmeetingdelsagovnetworkfiscalsustainabilityofhealthsystems2014.htm
This presentation was made by Kristina Garuoliene, Lithuania, at the 3rd Health Systems Joint Network meeting for Central, Eastern and South-eastern European Countries held in Vilnius, Lithuania, on 25-26 April 2019
Uzbekistan Pharmaceutical Country Report 9M 2019Eirhub
The Report uncovers 9M 2019 business trends of the pharmaceutical market in Uzbekistan, reviews its healthcare system, portrays its epidemiology and demographics. It also depicts pharma regulation features in Uzbekistan including a step-by-step process of the marketing authorization procedure for pharma products. It offers insight into the country’s sociopolitical development since independence, describes recent economic trends, and provides the local pharmaceutical sales forecast for the next three years (2019-2021).
2011 presentation to House Public Safety Appropriations Subcommitteeocpslides
Earlier this week, Director Jones presented this powerpoint presentation to the House Public Safety Appropriations Subcommittee. The Director thoroughly conveyed what an efficiently run agency the DOC is, as well as the desperate need for a supplemental, due in large part to unfunded offender population growth. The committee members had many questions, but didn't give an indication of whether or not a supplemental could be expected.
Assessing the European Commission's Proposal to Revise the Clinical Trial Dir...Cognizant
With a revision of the clinical trials directive impending, we offer a six-stage process for life sciences organizations to best prepare to capitalize on the changes in the CTD.
Budgeting for healthcare - Camila Vammalle, OECDOECD Governance
This presentation was made by Camila Vammalle, OECD, at the 11th Annual Meeting of Central, Eastern and South-Eastern Senior Budget Officials (CESEE SBO) held in Warsaw, Poland, on 21-22 May 2015.
mHealth israel_EU Go-To-Market for Digital Health, Julien Venne, European Con...Levi Shapiro
Presentation for mHealth Israel about "EU Go-To-Market for Digital Health", by Julien Venne, Strategic Advisory, European Connected Healthcare Alliance, Oct, 2016
Structure and governance of financing - Tamas Evetovits, WHOOECD Governance
This presentation was made by Tamas Evetovits, WHO, at the 2nd Health Systems joint Network Meeting for Central, Eastern and Southeastern European Countries held in Tallinn, Estonia, on 1-2 December 2016
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizens’ Health", on 5 March 2014, Athens, Greece.
This presentation was made by at the 3rd Health Systems Joint Network meeting for Central, Eastern and South-eastern European Countries held in Vilnius, Lithuania, on 25-26 April 2019
The Covid-19 pandemic is affecting everyone around the globe and leaves none of us untouched. However, much of the focus in international media has been on the most affected countries and richer countries in East Asia, the European Union and the United States with less attention given to countries around the Baltic Sea, in Eastern Europe and the Caucasus. Since the FREE Network includes research and policy institutes in Belarus (BEROC), Latvia (BICEPS), Russia (CEFIR@NES), Poland (CenEA), Georgia (ISET), Ukraine (KSE) and Sweden (SITE), we are uniquely placed to provide a comprehensive regional perspective on the pandemic with examples of very different strategies implemented in the countries concerned.
In this presentation experts from FREE NETWORK provide a first overview of how countries in the region have fared in the pandemic and allow for a better understanding of what governments have done, how people have responded, how other countries are being portrayed in the national media, and what the current discussions focus on.
For more information please visit our website: https://freepolicybriefs.org/
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the Advanced Training and Conference on Health Economics (24 June 2015, Budapest, Hungary)
This presentation is part of the report presented by the WHO Regional Director Zsuzsanna Jakab at the 63rd session of the WHO Regional Committee for Europe in Çeşme Izmir, Turkey, on 16 September 2013.
Sustainability and transition - Maris Jesse, EstoniaOECD Governance
This presentation was made by Maris Jesse, Estonia, at the 2nd Health Systems Joint Network Meeting for Central, Eastern and Southeastern European Countries held in Tallinn, Estonia, on 1-2 December 2016
Presentation delivered by Dr Zsuzsanna Jakab, Regional Director WHO Europe, at the international health forum (Ashgabat, Turkmenistan, 21-22 July 2015)
Performance budgeting in health - Svetlana Batare, LatviaOECD Governance
This presentation was made by Svetlana Batare, Latvia, at the 3rd Health Systems Joint Network meeting for Central, Eastern and South-eastern European Countries held in Vilnius, Lithuania, on 25-26 April 2019
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Dr Adriana liptokova The Slovak way on how to improve the Healthcare system efficiency
1. The Slovak W ay on how to I mprove the H ealthcare S ystem E fficiency Adriana Liptakova, MD, PhD Ministry of Health Slovakia
2.
3.
4.
5.
6. www.hpi.sk Healthcare Surveillance Authority Healthcare Insurance company Healthcare providers Ministry of Health Municipalities Government Professional Associations admission licence admission Insured person payer Healthcare provided Payment of insurance application inspection inspection contract
7. 1 HIC 2 HIC www.hpi.sk 67% 33% Healthcare insurance companies Healthcare providers Ministry of Health Gov. Municipalities Ministry of Transportation, Post and Telecommunication Private owners Common HIC Healthcare Surveillance Authority Departmental healthcare facilities Pharmacies Outpatient rooms Hospitals Emergency services Specialized hospitals University and faculty hospitals Ministry of Defense Ministry of Interior Affairs General HIC hospitals Outpatient clinics Emergency services Outpatient clinics Private HIC inspection inspection
8.
9.
10.
11. NCHI, 2010 23 Košice 25 Prešov 25 Banská Bystrica 13 Žilina 16 Nitra 12 Trenčín 9 Trnava 24 Bratislava 147 Slovakia In-patient Hospitals Area 2009
12. Physicians and nurses World Health Statistics WHO,2010) 67245 (158) 13141 (31) Ireland 35757 (66) 16868 (31) Slovakia Nurses and midwifes (per 10 000 population) Physicians (per 10 000 population) 2000-2009
14. Health expenditure as a share (%) of GDP in the WHO European Region, 2008, WHO estimates Slovakia 7,8% Ireland 8,7%
15. Health expenditure in US$PPP per capita in the WHO European Region, 2008, WHO estimates Source: WHO, Health for All Database, updated July 2010 Slovakia 1717 USD Ireland 3676 USD
24. Next steps for further improvements Report on Current Healthcare in Slovakia, in process GP - Payments per capita Outpatient specialists – DRG Inpatient healthcare - DRG Payment mechanisms University hospital in Bratislava Hospitals Reform of Funds Basic benefit package Financing Future options Area